ArticleThe American journal of case reports2026
Percutaneous Transcatheter Embolization for Recurrent Cerebral Embolism Due to Pulmonary Arteriovenous Malformation.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Pulmonary arteriovenous malformations (PAVMs) are rare structural vascular abnormalities that create communications between pulmonary arteries and veins, resulting in right-to-left shunts. PAVMs are often asymptomatic; however, patients may exhibit a range of clinical symptoms, including dyspnea, hemoptysis, chest pain, and cyanosis. Common serious complications include cerebrovascular events (eg, paradoxical embolism resulting in stroke or transient ischemic attack) and infectious complications (eg, brain abscess). PAVMs do not always require treatment; management should be guided by factors such as feeding artery size and patient symptoms. When intervention is indicated, percutaneous transcatheter embolization is the primary treatment and demonstrates efficacy in most cases. This report describes a case of recurrent cerebral embolism attributed to an undiagnosed PAVM, which was treated with percutaneous transcatheter embolization. CASE REPORT A 67-year-old man lacking prior medical history or medication use experienced recurrent cerebral embolism within 3 months despite therapeutic anticoagulation. The paradoxical embolism was attributed to a PAVM diagnosed by contrast-enhanced chest computed tomography. Subsequent transcatheter embolization of the PAVM was successfully performed. No recurrence was observed at the 4-year follow-up. CONCLUSIONS In cases of unexplained cerebral embolism, PAVMs should be considered a potential underlying etiology. Hemorrhagic transformation requires careful risk assessment but is not an absolute contraindication to percutaneous transcatheter embolization. Timely diagnosis and embolization are essential to prevent disabling recurrent events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.